Market Overview:
The global transplantation diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of organ failures, rising demand for organ transplants, and technological advancements in transplantation diagnostics. The global transplantation diagnostics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments and reagents. Instruments are further sub-segmented into analyzers and separators. and nucleic acids (DNA probes). On the basis of application, the market is segmented into hospital and clinic settings.
Product Definition:
Transplantation diagnostics is the study of how well a transplanted organ is functioning. It can be used to determine if a transplant is working properly, or if it is in danger of failing. Transplantation diagnostics can also help doctors determine how best to treat a transplant patient.
Instruments:
Instruments, it's usage.
The global increase in the number of organ failures and shortage of organs for transplant is driving the demand for innovative diagnostic technologies to improve organ recovery rate. The growing need to develop novel techniques that can overcome biological limitations associated with transplants is expected to drive research activities during the forecast period.
Global Instruments, it's usage.
Reagents:
Reagents are chemicals that help in detecting or identifying a disease condition. Reagents used for transplantation diagnostics include histological reagents, tissue culture media, and cell line development reagents among others. The demand for these products is increasing due to the growing number of organ transplant procedures globally as well as technological advancements in the field of diagnostic reagent manufacturing.
Application Insights:
The hospital application segment dominated the global transplantation diagnostics market in 2017. This can be attributed to a large number of hospitals and healthcare centers that perform transplant surgeries on a regular basis. Furthermore, increasing government initiatives for improving organ donation rates is expected to boost the demand for these tests in near future.
Clinic applications are anticipated to witness lucrative growth over the forecast period owing to an increase in demand for minimally invasive procedures among patients seeking medical advice or treatment at clinics and walk-in centers. Minimally invasive procedures require highly skilled professionals, who often travel with specialized equipment and instruments during such visits; thus resulting in higher adoption of diagnostic solutions across clinics worldwide.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in organ transplantation activities, high healthcare expenditure and technological advancements. The region is expected to maintain its position during the forecast period due to increasing R&D investments by various companies and an increase in healthcare spending.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving infrastructure, growing medical tourism, awareness campaigns regarding organ donation & transplantation and government initiatives for boosting transplants. For instance, China has implemented several policies that encourage donations of organs at hospitals as well as public venues like train stations and airports among others.
Growth Factors:
- Increasing incidence of organ failures and the subsequent need for transplantation is expected to drive the demand for transplantation diagnostics over the forecast period.
- Rising awareness about organ donation and transplants is anticipated to propel the market growth.
- Technological advancements in transplantation diagnostics are likely to provide lucrative opportunities for market players.
- Growing number of private clinics offering transplant-related services is projected to boost the demand for transplantation diagnostics products and services over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transplantation Diagnostics Market Research Report
By Type
Instruments, Reagents
By Application
Hospital, Clinic
By Companies
Bio-Rad Laboratories, Roche, QIAGEN, Immucor, bioMérieux, BD, CareDx, Illumina, GenDx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Transplantation Diagnostics Market Report Segments:
The global Transplantation Diagnostics market is segmented on the basis of:
Types
Instruments, Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- Roche
- QIAGEN
- Immucor
- bioMérieux
- BD
- CareDx
- Illumina
- GenDx
Highlights of The Transplantation Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Reagents
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transplantation Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transplantation diagnostics is a field of medical science that uses laboratory tests to diagnose and monitor the health of transplant patients. These tests may include blood work, imaging studies, and genetic testing.
Some of the key players operating in the transplantation diagnostics market are Bio-Rad Laboratories, Roche, QIAGEN, Immucor, bioM©rieux, BD, CareDx, Illumina, GenDx.
The transplantation diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transplantation Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transplantation Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transplantation Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transplantation Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transplantation Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Transplantation Diagnostics Market Size and Y-o-Y Growth
4.5.2 Transplantation Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Transplantation Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Transplantation Diagnostics Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Transplantation Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Transplantation Diagnostics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transplantation Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transplantation Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Transplantation Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Transplantation Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Transplantation Diagnostics Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Transplantation Diagnostics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Transplantation Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Transplantation Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Transplantation Diagnostics Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Transplantation Diagnostics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Transplantation Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Transplantation Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Transplantation Diagnostics Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Transplantation Diagnostics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Transplantation Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Transplantation Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Transplantation Diagnostics Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Transplantation Diagnostics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Transplantation Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Transplantation Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Transplantation Diagnostics Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Transplantation Diagnostics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transplantation Diagnostics Market: Competitive Dashboard
14.2 Global Transplantation Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Roche
14.3.3 QIAGEN
14.3.4 Immucor
14.3.5 bioMérieux
14.3.6 BD
14.3.7 CareDx
14.3.8 Illumina
14.3.9 GenDx
